Abiopharma

New Form 3 - CORE MOLDING TECHNOLOGIES INC <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0002086541-26-000004 <b>Size:</b> 3 KB

New Form 3 - CORE MOLDING TECHNOLOGIES INC <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0002086410-26-000003 <b>Size:</b> 3 KB

(85% Positive) PROFOUND MEDICAL CORP. (PROF) Announces Enrollment Update for balanced Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

ZENTEK LTD. (ZTEK) Files Form 6-K

CAPTAIN Trial ComparingProfound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

Venture Global Announces Final Investment Decision and Financial Close for Phase 2 of CP2 LNG

L3Harris to Present at Upcoming Investor Conference

Avis aux porteurs d’Obligations Senior Préférés - FRCASA010944 - 3,40 % mars 2026 / 2036 - montant définitif

(99% Neutral) MITESCO, INC. (MITI) Announces Business Combination

Clearbridge Health Ltd Announcement

NewtekOne, Inc. Declares Dividends on Common Stock and Series B Preferred Shares

DEADLINE: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

DevvStream Reduces Debt by Approximately $5.9 Million, Net of an Additional $700,000 Loan to Support the Company’s Working Capital Needs

HTCO Launches U.S. Strategic Initiative Led by Chairman Christopher Nixon Cox, Establishes Independent Governance Committee for U.S. Operations

Kroger Brings Zepbound® KwikPen to Retail Pharmacy, Expanding Access and Savings for Self-Pay Patients